Abstract
Background and aims
Limited data exist regarding outcomes of acute variceal bleeding (AVB) in patients with acute-on-chronic liver failure (ACLF), especially in those with hepatic failure. We evaluated the outcomes of AVB in patients with ACLF in a multinational cohort of APASL ACLF Research Consortium (AARC).
Methods
Prospectively maintained data from AARC database on patients with ACLF who developed AVB (ACLF-AVB) was analysed. This data included demographic profile, severity of liver disease, and rebleeding and mortality in 6 weeks. These outcomes were compared with a propensity score matched (PSM) cohort of ACLF matched for severity of liver disease (MELD, AARC score) without AVB (ACLF without AVB).
Results
Of the 4434 ACLF patients, the outcomes in ACLF-AVB (n = 72) [mean age—46 ± 10.4 years, 93% males, 66% with alcoholic liver disease, 65% with alcoholic hepatitis, AARC score: 10.1 ± 2.2, MELD score: 34 (IQR: 27–40)] were compared with a PSM cohort selected in a ratio of 1:2 (n = 143) [mean age—44.9 ± 12.5 years, 82.5% males, 48% alcoholic liver disease, 55.7% alcoholic hepatitis, AARC score: 9.4 ± 1.5, MELD score: 32 (IQR: 24–40)] of ACLF-without AVB. Despite PSM, ACLF patients with AVB had a higher baseline HVPG than without AVB (25.00 [IQR: 23.00–28.00] vs. 17.00 [15.00–21.75] mmHg; p = 0.045). The 6-week mortality in ACLF patients with or without AVB was 70.8% and 53.8%, respectively (p = 0.025). The 6-week rebleeding rate was 23% in ACLF-AVB. Presence of ascites [hazard ratio (HR) 2.2 (95% CI 1.03–9.8), p = 0.026], AVB [HR 1.9 (95% CI 1.2–2.5, p = 0.03)], and MELD score [HR 1.7 (95% CI 1.1–2.1), p = 0.001] independently predicted mortality in the overall ACLF cohort.
Conclusion
Development of AVB confers poor outcomes in patients with ACLF with a high 6-week mortality. Elevated HVPG at baseline represents a potential risk factor for future AVB in ACLF.
Similar content being viewed by others
Abbreviations
- ACLF:
-
Acute on chronic liver failure
- APASL:
-
Asia Pacific association for study of liver diseases
- AVB:
-
Acute variceal bleeding
- AARC:
-
APASL ACLF Research Consortium
- HVPG:
-
Hepatic venous pressure gradient
- MELD:
-
Model for end stage liver disease
- PSM:
-
Propensity score matching
- SOFA:
-
Sequential organ failure assessment
References
Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390. https://doi.org/10.1007/s12072-019-09946-3
Augustin S, Muntaner L, Altamirano JT, et al. Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol. 2009;7(12):1347–1354. https://doi.org/10.1016/j.cgh.2009.08.011
Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003;98(3):653–659. https://doi.org/10.1111/j.1572-0241.2003.07294.x
Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146(2):412-419.e3. https://doi.org/10.1053/j.gastro.2013.10.018
Rout G, Sharma S, Gunjan D, et al. Development and validation of a novel model for outcomes in patients with cirrhosis and acute variceal bleeding. Dig Dis Sci. 2019;64(8):2327–2337. https://doi.org/10.1007/s10620-019-05557-y
Trebicka J, Gu W, Ibáñez-Samaniego L, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. J Hepatol. 2020. https://doi.org/10.1016/j.jhep.2020.04.024
Kumar R, Kerbert AJC, Sheikh MF, et al. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding. J Hepatol. 2021;74(1):66–79. https://doi.org/10.1016/j.jhep.2020.06.010
Sarin SK, Kumar A, Angus PW, et al. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for study of the liver recommendations. Hepatol Int. 2011;5(2):607–624. https://doi.org/10.1007/s12072-010-9236-9
de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752. https://doi.org/10.1016/j.jhep.2015.05.022
Garg H, Kumar A, Garg V, et al. Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure. J Gastroenterol Hepatol. 2013;28(8):1361–1367. https://doi.org/10.1111/jgh.12191
Mookerjee RP, Pavesi M, Thomsen KL, et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol. 2016;64(3):574–582. https://doi.org/10.1016/j.jhep.2015.10.018
Kumar M, Kainth S, Choudhury A, et al. Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial. Hepatol Int. 2019;13(6):800–813. https://doi.org/10.1007/s12072-019-09986-9
Bhutta AQ, Garcia-Tsao G, Reddy KR, et al. Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation. Aliment Pharmacol Ther. 2018;47(1):78–85. https://doi.org/10.1111/apt.14366
Tergast TL, Kimmann M, Laser H, et al. Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis. Aliment Pharmacol Ther. 2019;50(6):696–706. https://doi.org/10.1111/apt.15439
García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–2379. https://doi.org/10.1056/NEJMoa0910102
Lv Y, Yang Z, Liu L, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4(8):587–598. https://doi.org/10.1016/S2468-1253(19)30090-1
de Franchis R, Bosch J, Garcia-Tsao G, et al. BAVENO VII—RENEWING CONSENSUS IN PORTAL HYPERTENSION: report of the Baveno VII consensus workshop: personalized care in portal hypertension. J Hepatol. 2021. https://doi.org/10.1016/j.jhep.2021.12.022
Nicoară-Farcău O, Han G, Rudler M, et al. Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data. Gastroenterology. 2021;160(1):193-205.e10. https://doi.org/10.1053/j.gastro.2020.09.026
Shalimar, Sharma S, Gamanagatti SR, et al. Acute-on-chronic liver failure in budd-chiari syndrome: profile and predictors of outcome. Dig Dis Sci 2020;65(9):2719–2729. https://doi.org/10.1007/s10620-019-06005-7
Acknowledgements
APASL ACLF working Party Collaborators Detail: Shiv Kumar Sarin, Ashok Choudhury, Manoj K. Sharma, Rakhi Maiwall, Mamun Al Mahtab, Salimur Rahman, Sanjiv Saigal, Neeraj Saraf, A. S. Soin, Harshad Devarbhavi, Dong Joon Kim, R. K. Dhiman, Ajay Duseja, Sunil Taneja, C. E. Eapen, Ashish Goel, Q. Ning, Tao Chen, Ke Ma, Z. Duan, Chen Yu, Sombat Treeprasertsuk, S. S. Hamid, Amna S. Butt, Wasim Jafri, Akash Shukla, Vivek Saraswat, Soek Siam Tan, Ajit Sood, Vandana Midha, Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Sahu, P. N. Rao, Guan H. Lee, Seng G. Lim, Laurentius A. Lesmana, Cosmas Rinaldi Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dokmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, G. K. Lau, Md. Fazal Karim, Gamal Shiha, Rino Gani, Kemal Fariz Fariz Kalista, Man-Fung Yuen, Seema Alam, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil A. Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Ed Gane, Khin Maung Win, Wei Ting Chen, Mohd Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Sudhir, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender K. Yachha, Zeeshan Ahmad Wani, B. R. Thapa, Anoop Saraya, Shalimar, Ashish Kumar, Manav Wadhawan, Subash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh C. Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal, Lovkesh Anand, Tanmay Vyas, Rajan P. Mathur, Guresh Kumar, Priyanka Jain, Samba Siva Rao Pasupuleti, Yogesh K. Chawla, Abhijit Chowdhury, Shahinul Alam, Do Seon Song, Jin Mo Yang.
Funding
Authors have nothing to declare for any funding.
Author information
Authors and Affiliations
Consortia
Contributions
SS: conceptualisation, writing of original draft and revision. SA: conceptualisation, statistical analysis, revision of draft. AS: study design, conceptualisation and visualisation, study overview and critical revision of draft. AC: data collection and critical revision of the draft. MAM: data collection. MSA: data collection. SS: data collection. DJK: data collection. CEE: data collection. AG: data collection. QN team: data collection. HD: data collection. VS: data collection. AS: data collection. SH: Data collection. JH: data collection. S-ST: data collection. AA: data collection. MKS: data collection. MR: data collection. DJ: data collection. PNR: data collection. AK: data collection. HG: data collection. Guan Huei Lee: data collection. DZ: data collection. AS: data collection. OG: data collection. LAL: data collection. RCL: data collection. ST: data collection. NY: data collection. SS: data collection. HT: data collection. VMD: data collection. XS: data collection. FK: data collection. ZA: data collection. JDS: data collection. KFK: data collection. AS: data collection. DP: data collection. MO: data collection. SKS: study design, conceptualisation and visualisation, study overview and critical revision of draft.
Corresponding authors
Ethics declarations
Conflict of interest
Sanchit Sharma, Samagra Agarwal, Anoop Saraya, Ashok Choudhury, Mamun Al Mahtab, Mohd. Shahinul Alam, Sanjiv Saigal, Dong Joon Kim, C. E. Eapen, Ashish Goel, Qin Ning, Harshad Devarbhavi, Virendra Singh, Akash Shukla, Saeed Hamid, Jinhua Hu, Soek-Siam Tan, Anil Arora, Manoj Kumar Sahu, Mohd. Rela, Dinesh Jothimani, P. N. Rao, Anand Kulkarni, Hashmik Ghaznian, Guan Huei Lee, Duan Zhongping, Ajit Sood, Omesh Goyal, Laurentius A. Lesmana, Rinaldi C. Lesmana, Sombat Treeprasertsuk, Nan Yuemin, Samir Shah, Han Tao, V. M. Dayal, Xin Shaojie, Fazal Karim, Zaigham Abbas, Jose D. Sollano, Kemal Fariz Kalista, Ananta Shreshtha, Diana Payawal, Masao Omata, Shiv Kumar Sarin declare no competing interests.
Competing interests
None of the authors had any competing interests.
Financial disclosure
None.
Grant support
None.
Role of medical writer
None.
Patient consent
Waived off.
Guarantor of the article
Shiv Kumar Sarin and Anoop Saraya.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The members of the APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party are listed in Acknowledgements.
Rights and permissions
About this article
Cite this article
Sharma, S., Agarwal, S., Saraya, A. et al. Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC). Hepatol Int 16, 1234–1243 (2022). https://doi.org/10.1007/s12072-022-10372-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-022-10372-1